Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Yisheng Biopharma Announces Clearance from China FDA to Proceed with PIKA Rabies Vaccine Clinical Study 2018-10-08 21:00
China SXT Pharmaceuticals, Inc. Announces Effectiveness of Registration Statement on Form F-1 and Pricing the Initial Public Offering of its Ordinary Shares at $4.00 per Share 2018-09-29 05:15
NeuroAiD combined with rehabilitation has shown additive and sustained benefits on post-stroke recovery over 2 years after an initial 3-month treatment following stroke onset 2018-09-28 21:00
TransThera Biosciences Granted IND Approval from FDA to Soon Start Clinical Trials Targeting TNBC 2018-09-28 20:00
Launch of Special Chinese Big Data Platform for Cancer Genomics Informatics to Accelerate Innovation and Development of China's Precision Diagnosis and Treatment 2018-09-28 14:04
Luye Pharma Further Bolsters Global CNS Portfolio with Approval to Start LY03010 U.S. Clinical Trials 2018-09-27 18:41
ACT Genomics completed investment on route to become the leading DNA sequencing-based cancer solution provider in Asia 2018-09-26 12:07
Adlai Nortye Opens New US Headquarters, Solidifying its Position in the Global Pharma Industry 2018-09-25 22:05
AGC to Establish Mammalian cGMP-Compatible Contract Facility for Biopharmaceutical Development and Production at Chiba Plant 2018-09-25 14:00
Anaeropharma Science Signs Collaborative Research Agreement with Astellas on Creation of Novel Anti-Tumor Drugs Using Bifidobacterium 2018-09-25 13:00
PharmaBlock appoints Dr. Shijie Zhang as Chief Technology Officer 2018-09-20 17:40
I-Mab Wins Frost & Sullivan "2018 Best R&D Innovator Award (Biopharma Category)" 2018-09-19 15:33
Luye Pharma's Goserelin Acetate Extended-release Microspheres Start Phase III Clinical Trials in China, Paralleling Smooth Progress with U.S. Regulators 2018-09-07 12:22
WuXi AppTec Partner Hutchison MediPharma Receives Approval of Fruquintinib Capsules in China 2018-09-06 13:01
China YCT International Group Announces Corporate Name Change 2018-08-31 19:30
WuXi Biologics Selected into the Hang Seng HK 35 Index 2018-08-30 10:08
Luye Pharma Releases its Financial Results for the First Half of 2018: Double-Digit Growth in Core Product Sales, Exceeded Expectations in Sales, R&D and M&As 2018-08-29 17:40
KinoPharma and National Institutes for Quantum and Radiological Science and Technology Launch Collaborative Research Project for Exploring New Drug Development for Alzheimer's Disease 2018-08-29 14:00
China Biologic Responds to Lawsuit Filed in Cayman Islands by Former Chairman 2018-08-29 05:00
CStone's Anti-CTLA-4 Antibody CS1002 Receives IND Approval in China 2018-08-28 10:16
1 130 131 132 133 134 158